Colchicine in Vascular Inflammation Assessed With PET Imaging

NCT02162303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Vascular Disease

Interventions

DRUG: Colchicine
DRUG: Placebo

Sponsor

Montreal Heart Institute